2-Methoxy-6-methylpyrazine
Common Name: |
2-Methoxy-6-methylpyrazine |
IUPAC Name: |
2-methoxy-6-methylpyrazine |
Molecular Formula: |
C10H16O |
SMILES: |
CC1=CN=CC(=N1)OC |
Inchi: |
1S/C6H8N2O/c1-5-3-7-4-6(8-5)9-2/h3-4H,1-2H3 |
Inchi Key: |
MYDVJLOKNIAHPH-UHFFFAOYSA-N |
Cas No: |
2882-21-5 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
152.23 |
Mass (g/mol) |
124.064 |
Molar Refractivity |
47.80 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
2 |
Rings |
1 |
TPSA |
17.07 |
Hetero Atoms |
3 |
Heavy Atoms |
11 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
170.00 to 171.00 |
Vapor Pressure (mmHg@25.00 °C) |
1.931 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.70 |
LogP |
0.794 |
iLOGP |
2.23 |
XLOGP3 |
2.10 |
WLOGP |
2.57 |
MLOGP |
2.20 |
ESOL Log S |
-1.97 |
ESOL Solubility (mg/ml) |
1.61 |
ESOL Solubility (mol/l) |
0.011 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-2.09 |
Ali Solubility (mg/ml) |
1.24 |
Ali Solubility (mol/l) |
0.01 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-1.82 |
Silicos-IT Solubility (mg/ml) |
2.29 |
Silicos-IT Solubility (mol/l) |
0.02 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.74 |
Bioavailability Score |
0.55 |
Caco2 |
0 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.545 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.628 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
1 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |